University of Wisconsin
School of Medicine and Public Health

Amy Kind, MD, PHD

ASSOCIATE PROFESSOR

GERIATRICS Faculty

CLINICAL SCIENCE CENTER
600 HIGHLAND AVE
MADISON, WI 53792-0001

(608) 265-0852

Education

  • University of Wisconsin School of Medicine and Public Health – MD 
  • Massachusetts General Hospital, Boston, Massachusetts – Residency in Internal Medicine–Primary Care
  • University of Wisconsin School of Medicine and Public Health – Geriatrics Fellowship
  • William S. Middleton Memorial Veterans Hospital – Older Women’s Health Fellowship 
  • University of Wisconsin School of Medicine and Public Health – PhD in Population Health Sciences

Professional Activities

Dr. Amy Kind is a faculty member in the Division of Geriatrics and Gerontology within the Department of Medicine. She is the founding director of the Department of Medicine Health Services and Care Research Program. She also leads the Wisconsin Alzheimer’s Disease Research Center’s (ADRC) Dementia Care Research Core and co-leads the ADRC’s Research Education Core. In 2019, she was awarded the American Geriatric Society’s Thomas and Catherine Yoshikawa Award for Outstanding Scientific Achievement for Clinical Investigation and was elected to the American Society of Clinical Investigation (ASCI). She is a current fellow in the Executive Leadership in Academic Medicine program. Dr. Kind is also a dedicated clinician and serves as an outstanding research mentor, with many successfully funded mentees (National Institutes of Health [NIH] K awards, Diversity supplements). 

Dr. Kind currently serves as chair of the NIH Clinical Aging study section (NIA-C) and also chairs the Oversight and Advisory Committee of the Wisconsin Partnership Program, the University of Wisconsin School of Medicine and Public Health’s largest endowment-funded grant program. She has also served on numerous national and international advisory boards and committees, including a White House Task Force on Research and Development for Technology to Support Aging Adults and a number of Centers for Medicare and Medicaid (CMS) Technical Expert Panels. She has also previously served as a consultant to the State of Maryland Department of Health’s Health Services Cost Review Commission, advising on socio-demographic adjustments for hospital-focused policy. 

Clinical Specialties

Dr. Kind’s clinical interests include Alzheimer’s disease and related dementias and geriatric transitional care. She maintains an active clinical practice, serving as the director of both the VA Coordinated Transitional Care (C-TraC) Program and the VA Dementia and Cognitive Care Clinic and as an attending physician on the VA Geriatrics Consult Service, all through the Geriatrics Research, Education and Clinical Center (GRECC) of the William S. Middleton Memorial Veterans Hospital.

Research Interests

View Dr. Amy Kind’s publications at NCBI My Bibliography.

Dr. Kind leads a robust research program focused on improving health equity through cutting-edge interdisciplinary research on neighborhood disadvantage, the social determinants of health and Alzheimer’s disease. She and her team developed the Neighborhood Atlas, a free, first-of-its-kind online tool that quantifies socioeconomic disadvantage for every neighborhood in the U.S., including Puerto Rico. Her Atlas data have found widespread application including in the U.S. House of Representatives, NIH, CDC, VA, DOD, HHS, AARP, health systems and industry. Her work has had far-reaching policy impact, has been actively promoted by the NIH and published in top journals including New England Journal of Medicine.

To directly intervene on health disparities, Dr. Kind has successfully designed, implemented, and tested models of care to improve patient outcomes in low resource and safety net areas. Her interventions, such as low-cost models of care to improve coordination of care transitions, have been disseminated widely. Dr. Kind has multiple active R01s from the NIH/National Institute on Minority Health and Health Disparities, the NIH/National Institute on Aging, and routinely advises state, federal and international entities. Her most recent R01 will provide a novel window into the sociobiologic mechanisms underlying neighborhood disadvantage exposure and Alzheimer’s Disease neurobiology.